grapesharvester schreef op 28 oktober 2013 16:48:
[...]
The abstracts are now available online on the ACR website.
Analysis of the JAK1 selectivity of GLPG0634 and its main metabolite in different species, healthy volunteers and rheumatoid arthritis patients
Abstract # 478
Poster session - Sunday, October 27, 2013, 8.30 – 4.00 pm
An active metabolite contributes to the pharmacodynamics and efficacy of GLPG0634, a selective JAK1 inhibitor
Abstract # 1795
Oral session - Monday, October 28, 2013, 4.30 – 6.00 pm
The JAK1-selective inhibitor GLPG0634 is safe and rapidly reduces disease activity in patients with moderate to severe rheumatoid arthritis; results of a 4-week dose ranging study
Abstract # 2381
Poster session - Tuesday, October 29, 2013, 8.30 – 4.00 pm
De oral presentation deze middag en de poster session morgen zijn iets interessanter dan wat gisteren in een poster sessie te presenteren was.